ADC Therapeutics SA Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ADC Therapeutics SA quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q3 2024.
  • ADC Therapeutics SA Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $9.19M.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $9.19M Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $9.69M Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $10.1M Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $10.5M +$3.61M +52.2% Dec 31, 2023 10-Q 2024-11-07
Q4 2022 $6.91M Dec 31, 2022 10-K 2024-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.